Long-Acting Reversible Contraception Initiation Among Adolescents After an American Academy of Pediatrics Policy Statement

Bianca A Allison; Victor Ritter; Feng-Chang Lin; Kori B Flower; Martha F Perry

doi:10.1001/jamapediatrics.2023.5932

Long-Acting Reversible Contraception Initiation Among Adolescents After an American Academy of Pediatrics Policy Statement

JAMA Pediatr. 2024 Mar 1;178(3):306-308. doi: 10.1001/jamapediatrics.2023.5932.

Authors

Bianca A Allison¹, Victor Ritter², Feng-Chang Lin³, Kori B Flower¹, Martha F Perry⁴

Affiliations

¹ Division of General Pediatrics and Adolescent Medicine, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill.
² Quantitative Sciences Unit, Stanford School of Medicine, Palo Alto, California.
³ Department of Biostatistics, University of North Carolina Gillings School of Global Public Health, Chapel Hill.
⁴ Division of Adolescent and Young Adult Medicine, Department of Pediatrics, Children's National Hospital, Washington, DC.

PMID: 38190303
PMCID: PMC10775076 (available on 2025-01-08)
DOI: 10.1001/jamapediatrics.2023.5932

No abstract available

Plain language summary

This cross-sectional study compares monthly rates of long-acting reversible contraception (LARC) insertions among adolescents before and after an American Academy of Pediatrics (AAP) policy statement recommending LARC for this age group.

MeSH terms

Adolescent
Child
Contraception
Female
Humans
Long-Acting Reversible Contraception*
Policy
Pregnancy
Pregnancy in Adolescence* / prevention & control
United States